Human Genome Epidemiology Literature Finder
|
Records 1 - 10 (of 10 Records) |
| Query Trace: Glioblastoma and MUT[original query] |
|---|
| Secondary glioblastomas with IDH1/2 mutations have longer glioma history from preceding lower-grade gliomas. Brain tumor pathology 2013 Mar . Ohno M, Narita Y, Miyakita Y, Matsushita Y, Yoshida A, Fukushima S, Ichimura K, Shibui S |
| Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial. Neuro-oncology 2015 Sep . Dubbink Hendrikus J, Atmodimedjo Peggy N, Kros Johan M, French Pim J, Sanson Marc, Idbaih Ahmed, Wesseling Pieter, Enting Roelien, Spliet Wim, Tijssen Cees, Dinjens Winand N M, Gorlia Thierry, van den Bent Martin |
| Human TERT promoter mutation enables survival advantage from MGMT promoter methylation in IDH1 wild-type primary glioblastoma treated by standard chemoradiotherapy. Neuro-oncology 2016 Aug . Nguyen HuyTram N, Lie Amy, Li Tie, Chowdhury Reshmi, Liu Fei, Ozer Byram, Wei Bowen, Green Richard M, Ellingson Benjamin M, Wang He-Jing, Elashoff Robert, Liau Linda M, Yong William H, Nghiemphu Phioanh L, Cloughesy Timothy, Lai Albe |
| Adult infiltrating gliomas with WHO 2016 integrated diagnosis: additional prognostic roles of ATRX and TERT. Acta neuropathologica 2017 Mar . Pekmezci Melike, Rice Terri, Molinaro Annette M, Walsh Kyle M, Decker Paul A, Hansen Helen, Sicotte Hugues, Kollmeyer Thomas M, McCoy Lucie S, Sarkar Gobinda, Perry Arie, Giannini Caterina, Tihan Tarik, Berger Mitchel S, Wiemels Joseph L, Bracci Paige M, Eckel-Passow Jeanette E, Lachance Daniel H, Clarke Jennifer, Taylor Jennie W, Luks Tracy, Wiencke John K, Jenkins Robert B, Wrensch Margaret |
| Identification of time-to-peak on dynamic 18F-FET-PET as a prognostic marker specifically in IDH1/2 mutant diffuse astrocytoma. Neuro-oncology 2017 Aug . Suchorska Bogdana, Giese Armin, Biczok Annamaria, Unterrainer Marcus, Weller Michael, Drexler Mark, Bartenstein Peter, Schüller Ulrich, Tonn Jörg-Christian, Albert Nathalie |
| ATM mutations improve radio-sensitivity in wild-type isocitrate dehydrogenase-associated high-grade glioma: retrospective analysis using next-generation sequencing data. Radiation oncology (London, England) 2020 Jul 15 (1): 184. Kim Nalee, Kim Se Hoon, Kang Seok-Gu, Moon Ju Hyung, Cho Jaeho, Suh Chang-Ok, In Yoon Hong, Chang Jong H |
| Pro-inflammatory and proliferative microglia drive progression of glioblastoma. Cell reports 2021 9 36 (11): 109718. Liu Hailong, Sun Youliang, Zhang Qian, Jin Wei, Gordon Renata E, Zhang Yanyang, Wang Jian, Sun Caihong, Wang Zeyuan John, Qi Xueling, Zhang Junping, Huang Boyuan, Gui Qiuping, Yuan Hongyu, Chen Ling, Ma Xiaodong, Fang Chuan, Liu Yong-Qiang, Yu Xinguang, Feng Shi |
| High IER5 Gene Expression Is Associated With Poor Prognosis in Glioma Patients. Frontiers in cell and developmental biology 2021 7 9 679684. Wu Zijun, Wang Dan, Zeng Fanxin, Zhang Yanrong, Zhu Guannan, Ma Yiqi, Song Bin, Lui Su, Wu M |
| IDH-wild type glioblastomas featuring at least 30% giant cells are characterized by frequent RB1 and NF1 alterations and hypermutation. Acta neuropathologica communications 2021 12 9 (1): 200. Barresi Valeria, Simbolo Michele, Mafficini Andrea, Martini Maurizio, Calicchia Martina, Piredda Maria Liliana, Ciaparrone Chiara, Bonizzato Giada, Ammendola Serena, Caffo Maria, Pinna Giampietro, Sala Francesco, Lawlor Rita Teresa, Ghimenton Claudio, Scarpa Al |
| Germline ALK variations are associated with a poor prognosis in glioma and IDH-wildtype glioblastoma. Journal of neuro-oncology 2021 1 152 (1): 27-36. Bu Linghao, Hameed N U Farrukh, Luo Chen, Hong Pengjie, Zhou Xiaoyu, Wang Shengzhou, Wu Shu |
- Page last reviewed:Feb 1, 2024
- Content source: